Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index
- PMID: 31887811
- PMCID: PMC7492496
- DOI: 10.5009/gnl19236
Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index
Abstract
This review provides an update on the characteristics of nonalcoholic fatty liver disease (NAFLD), with a focus on the effects of age, sex, and body mass index. Age is a risk factor for NAFLD progression; however, extremely old patients have unique features, namely, the associations between metabolic comorbidities and NAFLD are weaker and NAFLD is not a risk factor for mortality. The prevalence of NAFLD is higher in men than in premenopausal women, whereas the reverse is true after menopause. Thus, before menopause, estrogen may have protective effects against NAFLD. Our hospital data showed that over 25% of male patients with NAFLD and almost 40% of female patients with NAFLD, especially elderly patients, were nonobese. Although histological steatosis and activity were associated with body mass index, the prevalence of nonalcoholic steatohepatitis was not. The prevalence of advanced fibrosis showed a significant sex difference. Advanced fibrosis was significantly more frequent among severely obese men but the prevalence was lower among severely obese women. This difference could be because a substantial proportion of severely obese women were premenopausal; thus, estrogen may have much stronger effects on the development of fibrosis than on obesity. Further studies are required to develop tailored management strategies.
Keywords: Age; Body mass index; Lean NAFLD; Non-alcoholic fatty liver disease; Obesity; sex difference.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures





Similar articles
-
Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign.J Gastroenterol Hepatol. 2019 Aug;34(8):1404-1410. doi: 10.1111/jgh.14585. Epub 2019 Jan 15. J Gastroenterol Hepatol. 2019. PMID: 30590868
-
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26. Clin Gastroenterol Hepatol. 2017. PMID: 28554682
-
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.J Gastroenterol Hepatol. 2022 Oct;37(10):1901-1910. doi: 10.1111/jgh.15936. Epub 2022 Jul 13. J Gastroenterol Hepatol. 2022. PMID: 35790343
-
Nonobese Fatty Liver Disease.Clin Gastroenterol Hepatol. 2017 Apr;15(4):474-485. doi: 10.1016/j.cgh.2016.08.028. Epub 2016 Aug 28. Clin Gastroenterol Hepatol. 2017. PMID: 27581063 Review.
-
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12. Lancet Gastroenterol Hepatol. 2020. PMID: 32413340
Cited by
-
Uncoupling hepatic insulin resistance - hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes.Front Endocrinol (Lausanne). 2023 Jun 15;14:1193373. doi: 10.3389/fendo.2023.1193373. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37396181 Free PMC article. Review.
-
The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for screening metabolic dysfunction-associated steatotic liver disease: an analysis from a gender perspective.Lipids Health Dis. 2024 Sep 27;23(1):311. doi: 10.1186/s12944-024-02299-3. Lipids Health Dis. 2024. PMID: 39334354 Free PMC article.
-
A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis.Front Endocrinol (Lausanne). 2023 Jul 7;14:1188214. doi: 10.3389/fendo.2023.1188214. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37484966 Free PMC article.
-
Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study.Intest Res. 2023 Oct;21(4):471-480. doi: 10.5217/ir.2023.00035. Epub 2023 Aug 11. Intest Res. 2023. PMID: 37559192 Free PMC article.
-
Identification of MAP3K4 as a novel regulation factor of hepatic lipid metabolism in non-alcoholic fatty liver disease.J Transl Med. 2022 Nov 14;20(1):529. doi: 10.1186/s12967-022-03734-8. J Transl Med. 2022. PMID: 36376950 Free PMC article.
References
-
- European Association for the Study of the Liver (EASL), author; European Association for the Study of Diabetes (EASD), author; European Association for the Study of Obesity (EASO), author EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–1402. doi: 10.1016/j.jhep.2015.11.004. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical